I’m on holiday but want to share our latest published work on alpha synuclein, before I get beaten to it by The Science of Parkinson's. I will post the highlights in the new year. Even is you do not do PD research look at it for the amazing images!! James Wiseman rdcu.be/d4Vzd

Nice recap

Happy New year everyone! Let make 2025 a good one!!#2025newyear

Two new papers on #parkinsons and #MSA accepted this week. The Science of Parkinson's I’ll better not go on holiday anytime soon or you’ll scoop me again. 😉

🧠🌍 Quiz Time! Take a close look at this image: 🗺️ ❓ Can you name these three countries? Hint: They share a surprising connection to Parkinson's disease. Drop your answers below and let's discuss! 🧬🗨️ #Parkinsons #HealthQuiz

Man, James Wiseman is a beast! Two papers in 1 week! In a new paper with Victor Dieriks & colleagues, he presents a refinement of the RT-QuIC protocol & analysis pipeline that can distinguish between #Parkinsons & #MSA, plus between MSA phenotypes …alneurodegeneration.biomedcentral.com/articles/10.11…

Prof Glenda Halliday deserves a lot of credit on this one. Her pathological knowledge of the brain is beyond impressive!

Our work on MSA in the news nzherald.co.nz/nz/groundbreak…

Round table at the Synuclein meeting in Cambridge with people with Parkinson’s on the first day. Great initiative from the organisers to give them a voice at this meeting. #Syn2025 #Parkinsons

Great meeting at Synuclein 2025 — always inspiring science and community. Even better seeing my PhD students, Eden Yin and Kreesan Reddy shine in action! Also great to see all the CBR kiwis in Cambridge #Syn2025 #Synuclein2025